Search

everythinglearnresearchcommunity

for

Search:↓

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Blocking certain immune signals can reduce skin damage from radiation therapy.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

Cancer treatments often cause skin, nail, and hair problems.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Targeted cancer therapies often cause serious skin problems that need careful management.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Docetaxel is effective against various cancers but mainly causes neutropenia.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Researchers found a safe and effective way to pick genetically modified skin cells with high growth potential using CD24.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.